Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Cirillo

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
p53 but not bcl-2 immunostaining is predictive of poor clinical complete response to primary chemotherapy in breast cancer patientsA Bottini, A Berruti, A Bersiga, et al.
International Journal of Oncology|July 17, 1998
Cytotoxic and antiproliferative activity of the CMF regimen administered in association with tamoxifen as primary chemotherapy in breast cancer patientsA Bottini, A Berruti, A Bersiga, et al.
Journal of Medicinal Chemistry|October 17, 2003
Structure-activity relationships of the p38alpha MAP kinase inhibitor 1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)naph- thalen-1-yl]urea (BIRB 796)John Regan, Alison Capolino, Pier F Cirillo, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2007
New modifications to the area of pyrazole-naphthyl urea based p38 MAP kinase inhibitors that bind to the adenine/ATP siteNeil Moss, Steffen Breitfelder, Raj Betageri, et al.
Heart (British Cardiac Society)|November 16, 2006
Safety of granulocyte-colony-stimulating factor in acute myocardial infarction (the Rigenera study)A M Leone, L Galiuto, S Rutella, et al.
Breast Cancer Research : BCR|July 17, 2023
RAGE inhibition blunts insulin-induced oncogenic signals in breast cancerM G Muoio, M Pellegrino, V Rapicavoli, et al.
Breast Cancer Research : BCR|August 10, 2023
Publisher Correction: RAGE inhibition blunts insulin-induced oncogenic signals in breast cancerM G Muoio, M Pellegrino, V Rapicavoli, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 29, 2021
Diagnostic Approach to Acute Liver Failure in Children: A Position Paper by the SIGENP Liver Disease Working GroupA Di Giorgio, E Bartolini, P L Calvo, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2011
1,4-Diazepane compounds as potent and selective CB2 agonists: optimization of metabolic stabilityDoris Riether, Lifen Wu, Pier F Cirillo, et al.
Bioorganic & Medicinal Chemistry Letters|April 10, 2009
Discovery and characterization of the N-phenyl-N'-naphthylurea class of p38 kinase inhibitorsPier F Cirillo, Eugene R Hickey, Neil Moss, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
p53 but not bcl-2 immunostaining is predictive of poor clinical complete response to primary chemotherapy in breast cancer patientsA Bottini, A Berruti, A Bersiga, et al.
International Journal of Oncology|July 17, 1998
Cytotoxic and antiproliferative activity of the CMF regimen administered in association with tamoxifen as primary chemotherapy in breast cancer patientsA Bottini, A Berruti, A Bersiga, et al.
Journal of Medicinal Chemistry|October 17, 2003
Structure-activity relationships of the p38alpha MAP kinase inhibitor 1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)naph- thalen-1-yl]urea (BIRB 796)John Regan, Alison Capolino, Pier F Cirillo, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2007
New modifications to the area of pyrazole-naphthyl urea based p38 MAP kinase inhibitors that bind to the adenine/ATP siteNeil Moss, Steffen Breitfelder, Raj Betageri, et al.
Heart (British Cardiac Society)|November 16, 2006
Safety of granulocyte-colony-stimulating factor in acute myocardial infarction (the Rigenera study)A M Leone, L Galiuto, S Rutella, et al.
Breast Cancer Research : BCR|July 17, 2023
RAGE inhibition blunts insulin-induced oncogenic signals in breast cancerM G Muoio, M Pellegrino, V Rapicavoli, et al.
Breast Cancer Research : BCR|August 10, 2023
Publisher Correction: RAGE inhibition blunts insulin-induced oncogenic signals in breast cancerM G Muoio, M Pellegrino, V Rapicavoli, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 29, 2021
Diagnostic Approach to Acute Liver Failure in Children: A Position Paper by the SIGENP Liver Disease Working GroupA Di Giorgio, E Bartolini, P L Calvo, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2011
1,4-Diazepane compounds as potent and selective CB2 agonists: optimization of metabolic stabilityDoris Riether, Lifen Wu, Pier F Cirillo, et al.
Bioorganic & Medicinal Chemistry Letters|April 10, 2009
Discovery and characterization of the N-phenyl-N'-naphthylurea class of p38 kinase inhibitorsPier F Cirillo, Eugene R Hickey, Neil Moss, et al.
Pageof 9